Lumida
/QSI
⌘K
Quantum-Si Inc

Quantum-Si Inc

QSI
$0.75USD-1.32%-0.01 today

MARKET CAP

164.2M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$3

AI Summary

Stalk
TrimMedium

QSI remains in a Stage 4 decline confirmed by the recent support failure, reinforcing a bearish medium-term bias. With price extended below the 9/21/50 EMAs and no exhaustion visible, immediate selling is less favorable. Better to defer execution and trim into minor rallies at intermediate resistance zones defined by the EMAs. A sustained reclaim of the 9EMA and 21EMA would invalidate the downward outlook.

  • Proteus platform aligns with >$4B non-human proteomics opportunity
  • Launch to detect 19–20 amino acids boosts sequencing precision
  • Q2 2026 revenue $344K vs $591K a year ago highlights steep decline
Full analysis →

Buying

5

institutions

Selling

3

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL5.23 M4.62 M+-8.19 M-55.5%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW3.13 M2.77 M+3.13 M+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL2.35 M2.08 M+-43.51 K+12.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY553.87 K490.18 K+435.97 K+437.1%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY332.94 K294.65 K+113.39 K+73.4%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW39.13 K34.63 K+39.13 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL17.07 K15.18 K+-66.45 K-75.4%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW13.63 K12.06 K+13.63 K+0.0%0.00%